Overall, Challenger’s financial results for FY2024 appear to have exceeded market expectations, particularly in terms of profitability and EPS growth, despite slightly lower total Life sales. The company’s performance has been recognized by an increased dividend and a positive outlook from most analysts.
Investors took a welcome breather to start the week as key inflation data is due over the next few days
Both bearish and bullish Investors were battered and bruised this week as the recovery in stocks continued following a major selloff earlier this week when concerns about an incoming recession took center stage and a recovery in the latter half of the week left us largely unchanged
This week, mega-cap earnings disappoint as investors ask “where’s the revenue”, US economy starts to show cracks and middle east conflict flares up (again)
Anticipating next week’s company earnings and economic figures.
Stay informed on the latest financial updates and trends with MPC Markets
ADD to Challenger (CGF) into Earnings on the 13th August
Investors breathed a sigh of relief as better-than-feared labor market data cooled worries that a recession may be on the horizon.
Investors enthusiasm to “buy the dip” faded within one session as equites turned lower mid-session in the US on a slump in Super Micro Computer pressured chips stocks, weighing on the broader market.
Balanced Portfolio – SELL 5% Resmed (RMD) Take +10% profit
We recommended buying ResMed Inc. (RMD) due to its potential for strong performance in the upcoming earnings season on the 29th of July
Global equites stabilized overnight as dip buyers piled into beaten down tech stocks following a rout a day earlier, though gains were limited amid lingers concerns about an economic slowdown.
In one of the scariest sessions I’ve seen since the GFC, global equities imploded overnight, led by a 13.5% fall in Japan’s Nikkei, the largest fall since the Black Monday crash back in 1987
A minor equities panic has started to spread across global markets in the last few sessions as investors grow increasingly concerned that the US economy will go into recession.
To reassure you, the MPC Markets Balanced Portfolio is defensively positioned and while we are still not immune to the broader market weakness, we have been wary a move like this could happen
